Skip to Content

New Drug Approvals Archive - July 2003

July 2003

Emtriva (emtricitabine) Capsules

Date of Approval: July 2, 2003
Company: Gilead Sciences, Inc.
Treatment for: HIV Infection

Emtriva (emtricitabine) is a nucleoside reverse transcriptase inhibitor (NRTI) used with other anti-HIV medicines to treat people with HIV infection.

Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension

Date of Approval: July 18, 2003
Company: Alcon Research, Ltd.
Treatment for: Acute Otitis Externa, Otitis Media

Ciprodex (ciprofloxacin/dexamethasone) is an antibiotic / anti-inflammatory combination used for the treatment of acute otitis media and acute otitis externa.

Clobex (clobetasol propionate) Lotion

Date of Approval: July 24, 2003
Company: Galderma Laboratories
Treatment for: Atopic Dermatitis, Psoriasis

Clobex (clobetasol) is a topical corticosteroid used to treat steroid-responsive dermatoses including moderate-to-severe atopic dermatitis and moderate-to-severe psoriasis.

Advate (antihemophilic factor [recombinant])

Date of Approval: July 25, 2003
Company: Baxter Healthcare Corp
Treatment for: Hemophilia A

Advate (antihemophilic factor [recombinant]) is indicated for use in hemophilia A (classical hemophilia) for the prevention and control of bleeding episodes, and also indicated in the perioperative management of patients with hemophilia A.

Aloxi (palonosetron) Injection

Date of Approval: July 25, 2003
Company: Helsinn Healthcare
Treatment for: Nausea/Vomiting -- Chemotherapy Induced

Aloxi (palonosetron) is a 5-HT3 receptor antagonist indicated for the prevention of nausea and vomiting associated with chemotherapy.

Zavesca (miglustat) Capsules

Date of Approval: July 31, 2003
Company: Actelion Pharmaceuticals
Treatment for: Gaucher Disease

Zavesca (miglustat) is a glucosylceramide synthase inhibitor indicated for the treatment of adult patients with mild to moderate type 1 Gaucher disease.

Clobex (clobetasol propionate) Lotion

Date of Approval: July 24, 2003
Company: Galderma Laboratories
Treatment for: Atopic Dermatitis, Psoriasis

Clobex (clobetasol) is a topical corticosteroid used to treat steroid-responsive dermatoses including moderate-to-severe atopic dermatitis and moderate-to-severe psoriasis.

New Drug Approvals Archive

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.